A Novel Bispecific Antibody to Target the Brain Tumor Microenvironment
Kyuson Yun, Ph.D.
Associate Professor
Department of Neurology
Houston Methodist Chair, Neurodegenerative Disease Research
Houston Methodist Research Institute
Weill Cornell Medical College
Pioneers in Biomedical Research Seminar
A Novel Bispecific Antibody to Target the Brain Tumor Microenvironment
Date: May 2, 2025
Time: 11 a.m. - 12 p.m.
In-person: Room G101 A/B, 4 Riverside Circle, Roanoke, Virginia
Virtual: Watch via Zoom
About this Seminar
While immunotherapies have shown remarkable efficacy in some cancers, most solid tumors, including brain cancers, are resistant to immunotherapies. Immunotherapies are ideal for treating brain cancers since immune cells can cross the blood brain barrier (BBB) and track and selectively kill infiltrating brain cancer cells while sparing normal brain cells. Unfortunately, most brain cancer trials with immunotherapies have failed to demonstrate significant benefits to brain cancer patients thus far. Dr. Yun and her team recently identified S100A4 as a critical regulator of immune suppressive myeloid and T cells in GBM through single cell sequencing analysis, and developed a novel S100A4 blocking antibody. To enhance BBB penetration, we also developed a bispecific antibody that crosses the BBB and reprograms the GBM TME to more an inflammatory state. Dr. Yun will discuss our progress in understanding the immune suppressive microenvironment in GBM and the therapeutic potential of a novel bispecific antibody for treating brain cancers.
Additional Details
This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Cancer Research Center — Roanoke. The Pioneers in Biomedical Research Seminar Series, which runs annually from September to May, has featured leading biomedical researchers from throughout the country since the program began in 2012. The lectures are also open to all members of the Virginia Tech community including graduate students, undergraduates, faculty, and staff, as well as the public.
You May Also Be Interested In...
-
Home Item
Molecular and Neurobiological Studies in Rett Syndrome and Other MECP2 Disorders , homeMay 1, 2025, 5:30 p.m. (Reception at 5 p.m.) | Huda Zoghbi, M.D., Professor, Pediatrics, Molecular and Human Genetics, Neuroscience, and Neurology; Director, Jan and Dan Duncan Neurological Research Institute, Baylor College of Medicine; Member, National Academy of Medicine | Maury Strauss Distinguished Public Lecture
-
Home Item
A Novel Bispecific Antibody to Target the Brain Tumor Microenvironment , homeMay 2, 2025, 11:00 a.m. | Khuson Yun, Ph.D., Associate Professor, Department of Neurology, Houston Methodist Chair, Neurodegenerative Disease Research, Houston Methodist Research Institute, Weill Cornell Medical College | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Center – Roanoke
-
Home Item
Transformation of Information from the External World by Cortical Circuits During Learning , homeMay 9, 2025, 11:00 a.m. | Alison Barth, Ph.D., Professor, Department of Biological Sciences, Carnegie Mellon University | Co-Sponsored by the Center for Neurobiology Research, Fralin Biomedical Research Institute
-
Home Item
The Role of Exercise in Memory Function , homeMay 23, 2025, 11:00 a.m. | Henriette van Praag, Ph.D., Associate Professor, Department of Biomedical Science, Charles E. Schmidt College of Medicine, Florida Atlantic University | Co-Sponsored by the Center for Exercise Medicine Research, Fralin Biomedical Research Institute
-
Home Item
Pathways and Regulation of Cardiac Nav1.5 Channel Trafficking in Adult Myocytes , homeMay 30, 2025, 11:00 a.m. | Gea-Ny Tseng, Ph.D., Professor, Department of Physiology and Biophysics, Virginia Commonwealth University School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Vascular and Heart Research
-
Home Item
Targeting Acquired Dependencies During Tumor Evolution , homeJune 6, 2025, 11:00 a.m. | Kris Wood, Ph.D., Associate Professor, Department of Pharmacology and Cancer Biology, Duke University School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Center – D.C.